Financial News

View more issues:

Articles in August, 2003 issue of Financial News

• Credit derivative accounting proves sticky for investors.
• Kingsmill looks for fresh start.
• Top CEOs show their confidence in recovery.
• WestLB admits it will offload finance unit.
• State Street's head of research departs.
• Home loans.
• Citigroup strategy seems to pay off.
• Analysts form scrum for oil.
• Hedge funds exploit short-selling loophole.
• Winners and losers in the equity rally.
• US IPOs rise 50% after launch.
• Disclosure war claims victim.
• Fidelity abandons alternatives.
• Morgan Stanley to face charges over contest.
• Hedge funds beaten by indices despite rise in July.
• Wolfson plans largest technology IPO for four years.
• Man delivers, but from behind closed doors.
• CapMan expands life science business.
• UK consulting firm looks to service boutiques.
• Recruitment consultant springs to life.
• Texas Capital shares rise 9% after $66m IPO.
• ING surprises with 15% profit rise to [euro]1.17bn.
• Brokerage sale hits Julius Bar's first-half profits.
• Gray to join de Broe from HSBC.
• Analysts call for non-deferral on expensed bank options.
• Edinburgh FM fired by investment trust.
• Bank of America and Goldman only banks to show fee growth.
• Pension holes dog buy-out deals.
• News in brief: Smith Barney hire.
• Who said the Finns made great diplomats?
• ADRs prove popular M&A tools.
• Thames River raids Baring AM for Wesinger hire.
• Accident Group chief points finger at HBOS.
• Simmons advises Candover consortium on ABB unit sale.
• Deutsche Bank unit is fined over H-P.
• European bankers double their fees from convertibles.
• Seven bidders expected for S&N's pubs estate.
• TradeWeb hires straight-through processing expert.
• Challenge to NYSE in email dispute.
• Principal buys high-yield specialist fund manager.
• Chairman of Swedish national fund investigated for insider trading.
• Reuters accused of widespread racism in US class-action lawsuit.
• Abingworth closes Europe's largest bioscience fund on $325m.
• Life science leads capital resurgence.
• Investors fail to discriminate.
• Liquidnet Europe in the black.
• Wall Street report slams 'cosy' NYSE.
• Barclays Capital hires for FX team.
• In brief: Philippe hire/Somerset tender/Swip pooled funds.
• RBS ready for acquisition cash call.
• Fidelity spins off short-selling unit.
• Commerzbank shares slide as provisions rise.
• JP Morgan and Morgan Stanley debut emerging market credit index.
• Founders net [pounds sterling]11m in HedgeFund sale.
• UBS Investment Bank profits up 14%.
• SEI launches pan-European small cap equity fund.
• BGI's iShares to close down all sector exchange traded funds.
• Carnival boss to embark on $1bn share disposal.
• CSAM Switzerland to axe 40 jobs.
• Basel II could cut private equity funding by [euro]10bn.
• NYSE pays out $139m to Richard Grasso.
• Fortis Investments revenues slide as clients pull mandates.
• JP Morgan wins fourth Austrian mandate in three months.
• New Nordic buy-out firm attracts [euro]100m.
• Day in the Life: Alastair Ross Goobey - portfolio career.
• Thomson Financial hires custody superstar Bilbe.
• News in brief: German banks arrange debut loan for AVA.
• Ex-CIBC leveraged debt bankers win deal at new advisory firm.
• Floors shun instant messages for dealing.
• Townsend's boat returns to the surface.
• MLIM scrambles for talent as managers quit.
• News in brief: Record inflows in second quarter.
• Ernst & Young revives float room as IPOs return.
• Project bond supply under threat from UK proposals.
• Companies struggle to come to terms with Sarbanes-Oxley.
• News in brief: SmartStream adds users.
• Threadneedle adds to global equity team.
• Merrill shares hit by internal wrangles.
• Self-regulation dominates MFA hedge fund guidelines.
• Toyota awarded elite triple-A rating.

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10